AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
Enhanced Device Offers a Marked Advancement in Closure Mountain View, California (January 11, 2011) – AccessClosure, Inc., the U.S. market
Pioneering Medical Innovations
Pioneering Medical Innovations
Enhanced Device Offers a Marked Advancement in Closure Mountain View, California (January 11, 2011) – AccessClosure, Inc., the U.S. market
PLEASANTON Calif., SINGAPORE and TOKYO, Jan. 10, 2011 /PRNewswire/ — TriReme Medical, Inc. (TriReme) today announced that it has signed
Successful US Commercial Deployment of Novel Peripheral Ultra-High-Pressure Angioplasty Balloon Mountain View, CA – January 7, 2011 – Hotspur Technologies,
Has Potential of Changing the Dynamics of an Underserved Market by setting a New Benchmark in Use of Catheters for
Portfolio of Vascular Closure Devices Expanded with Addition of the Bengal™ Mountain View, California (September 29, 2010) – AccessClosure, Inc,
WALTHAM, Mass., Aug. 11 /PRNewswire/ — Augmenix, Inc. announced today that Prof. Michael Eble and Dr. Michael Pinkawa of the
Mynx M5™ Offers Patients “Artery-Friendly” Closure Solution Mountain View, Calif (June 22, 2009) – AccessClosure today announced the newest addition
NextPlane’s enterprise class UC federation combines with Dexrex’s IM and SMS archival and retrieval capabilities to helps enterprises running multiple
I-Therapeutix, Inc. announced today that it has changed its corporate name to Ocular Therapeutix, Inc. Amar Sawhney, President and CEO-stated
Sometimes just getting FDA approval isn’t enough. AccessClosure got FDA clearance of its PMA vascular closure device, only to delay